KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Abbott Laboratories (ABT) Return on Invested Capital (2016 - 2025)

Abbott Laboratories (ABT) has disclosed Return on Invested Capital for 17 consecutive years, with 0.1% as the latest value for Q4 2025.

  • Quarterly Return on Invested Capital fell 16.0% to 0.1% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.1% through Dec 2025, down 16.0% year-over-year, with the annual reading at 0.1% for FY2025, 28.0% down from the prior year.
  • Return on Invested Capital hit 0.1% in Q4 2025 for Abbott Laboratories, down from 0.37% in the prior quarter.
  • In the past five years, Return on Invested Capital ranged from a high of 9.76% in Q3 2021 to a low of 3.22% in Q2 2021.
  • Historically, Return on Invested Capital has averaged 0.65% across 5 years, with a median of 0.37% in 2022.
  • Biggest five-year swings in Return on Invested Capital: skyrocketed 1003bps in 2021 and later crashed -1185bps in 2022.
  • Year by year, Return on Invested Capital stood at 0.76% in 2021, then surged by 96bps to 1.49% in 2022, then tumbled by -64bps to 0.53% in 2023, then plummeted by -52bps to 0.26% in 2024, then crashed by -63bps to 0.1% in 2025.
  • Business Quant data shows Return on Invested Capital for ABT at 0.1% in Q4 2025, 0.37% in Q3 2025, and 2.14% in Q2 2025.